Novartis AG (NVS)
Novartis Market Cap : 282.55B for May 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Roche Holding AG | 325.47B |
| AstraZeneca PLC | 281.60B |
| GSK Plc | 99.71B |
| Johnson & Johnson | 545.74B |
| Eli Lilly & Co. | 896.13B |
Market Cap Related Metrics
| PE Ratio | 21.10 |
| PS Ratio | 5.246 |
| PEG Ratio | 2.106 |
| Price to Book Value | 7.337 |
| Price to Free Cash Flow | 17.86 |
| Price | 148.08 |
| Earnings Yield | 4.74% |
| PEGY Ratio | 1.596 |
| Operating PE Ratio | 17.67 |
| Normalized PE Ratio | 20.07 |